A detailed history of Axq Capital, LP transactions in Astrazeneca PLC stock. As of the latest transaction made, Axq Capital, LP holds 6,244 shares of AZN stock, worth $401,239. This represents 0.15% of its overall portfolio holdings.

Number of Shares
6,244
Previous 5,884 6.12%
Holding current value
$401,239
Previous $459 Million 6.01%
% of portfolio
0.15%
Previous 0.11%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$76.67 - $87.62 $27,601 - $31,543
360 Added 6.12%
6,244 $486 Million
Q2 2024

Aug 13, 2024

BUY
$66.81 - $80.83 $393,110 - $475,603
5,884 New
5,884 $459 Million
Q4 2023

Feb 13, 2024

SELL
$61.89 - $69.28 $457,986 - $512,672
-7,400 Reduced 32.46%
15,400 $1.04 Billion
Q3 2023

Nov 14, 2023

BUY
$64.85 - $71.7 $1.48 Million - $1.63 Million
22,800 New
22,800 $1.54 Billion
Q4 2022

Feb 10, 2023

BUY
$54.21 - $70.44 $808,162 - $1.05 Million
14,908 New
14,908 $1.01 Billion

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $199B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Axq Capital, LP Portfolio

Follow Axq Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axq Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Axq Capital, LP with notifications on news.